A detailed history of Ellerson Group Inc /Adv transactions in Dexcom Inc stock. As of the latest transaction made, Ellerson Group Inc /Adv holds 62,248 shares of DXCM stock, worth $6.9 Million. This represents 6.6% of its overall portfolio holdings.

Number of Shares
62,248
Previous 64,568 3.59%
Holding current value
$6.9 Million
Previous $8.01 Billion 7.76%
% of portfolio
6.6%
Previous 6.95%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$114.22 - $140.1 $264,990 - $325,032
-2,320 Reduced 3.59%
62,248 $8.63 Billion
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $5,593 - $8,965
65 Added 0.1%
64,568 $6.02 Billion
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $273,751 - $318,805
-2,434 Reduced 3.64%
64,503 $8.29 Billion
Q1 2023

May 05, 2023

SELL
$104.0 - $122.92 $11,544 - $13,644
-111 Reduced 0.17%
66,937 $7.78 Billion
Q4 2022

Feb 09, 2023

BUY
$84.98 - $122.67 $5.7 Million - $8.22 Million
67,048 New
67,048 $7.59 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $42.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ellerson Group Inc /Adv Portfolio

Follow Ellerson Group Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellerson Group Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Ellerson Group Inc /Adv with notifications on news.